Mycobacterium ulcerans infection: control, diagnosis, and treatment

The Lancet Infectious Diseases
Vinciane SizaireFrançoise Portaels

Abstract

The skin disease Buruli ulcer, caused by Mycobacterium ulcerans, is the third most common mycobacterial disease after tuberculosis and leprosy and mainly affects remote rural African communities. Although the disease is known to be linked to contaminated water, the mode of transmission is not yet understood, which makes it difficult to propose control interventions. The disease is usually detected in its later stages, when it has caused substantial damage and disability. Surgery remains the treatment of choice. Although easy and effective in the early stages of the disease, treatment requires extended excisions and long hospitalisation for the advanced forms of the disease. Currently, no antibiotic treatment has proven effective for all forms of M ulcerans infection and research into a new vaccine is urgently needed. While the scientific community works on developing non-invasive and rapid diagnostic tools, the governments of endemic countries should implement active case finding and health education strategies in their affected communities to detect the disease in its early stages. We review the diagnosis, treatment, and control of Buruli ulcer and list priorities for research and development.

References

Jan 1, 1977·Transactions of the Royal Society of Tropical Medicine and Hygiene·P G SmithY P Rykushin
Aug 6, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·O AdjeiA Asiedu
Sep 29, 1999·Lancet·T S van der WerfK Asiedu
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·H DegaJ Grosset
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·A BentouchaJ Grosset
Mar 19, 2002·Emerging Infectious Diseases·George AmofahJonathan Addy
Aug 13, 2002·AIDS·R Christian JohnsonFrançoise Portaels
Aug 30, 2002·Applied and Environmental Microbiology·Laurent MarsollierBernard Carbonnelle
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Herve DegaJacques Grosset
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Laurent MarsollierStewart T Cole
Jul 19, 2003·Tropical Medicine & International Health : TM & IH·Isabelle AujoulatFrançoise Portaels
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nina PszollaFrançoise Portaels
Dec 9, 2003·International Journal of Antimicrobial Agents·Laurent MarsollierBernard Carbonnelle
Jan 9, 2004·Expert Review of Vaccines·Kris Huygen
May 1, 2004·Emerging Infectious Diseases·Janet T ScottFrançoise Portaels
Jun 23, 2004·Emerging Infectious Diseases·Christina Drummond, James R G Butler
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·R PhillipsA H J Kolk
Sep 4, 2004·Applied and Environmental Microbiology·Miriam EddyaniFrançoise Portaels
Oct 22, 2004·Emerging Infectious Diseases·Martine DebackerFrançoise Portaels
Dec 16, 2004·Tropical Medicine & International Health : TM & IH·M DebackerF Portaels
Jan 18, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Ilona C HospersTjip S van der Werf
Apr 15, 2005·Emerging Infectious Diseases·Martine DebackerFrançoise Portaels
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pratima L RaghunathanDavid A Ashford
May 10, 2005·International Journal of Systematic and Evolutionary Microbiology·Martha W RhodesChristopher A Ottinger

❮ Previous
Next ❯

Citations

Jan 23, 2008·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M StreitI Heinzer
Aug 28, 2012·Bulletin de la Société de pathologie exotique·B SakaP Pitché
Jul 12, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Annelies A MulderYmkje Stienstra
May 22, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·Anthony J Radford
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vera SiegmundGisela Bretzel
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Marie-Thérèse RufGerd Pluschke
Apr 24, 2009·Journal of Clinical Microbiology·Miriam EddyaniFrançoise Portaels
Nov 9, 2007·Journal of Clinical Microbiology·Miriam EddyaniFrançoise Portaels
Jan 1, 2011·Plastic Surgery International·Pius Agbenorku
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Jan 1, 2012·Infectious Diseases of Poverty·Mercy M AckumeyMitchell G Weiss
Dec 28, 2007·PLoS Neglected Tropical Diseases·Régis PouillotSara Eyangoh
Jun 24, 2009·PLoS Neglected Tropical Diseases·Klaudia PortenRebecca F Grais
Jul 21, 2010·PLoS Neglected Tropical Diseases·Ghislain Emmanuel SopohFrançoise Portaels
Jun 30, 2011·PLoS Neglected Tropical Diseases·Mercy M AckumeyMitchell G Weiss
Nov 1, 2011·PLoS Neglected Tropical Diseases·Claire L GordonPaul D R Johnson
Apr 18, 2012·PLoS Neglected Tropical Diseases·Anthony AblordeyHarutaka Katano
Jul 23, 2013·PLoS Neglected Tropical Diseases·N Deborah FriedmanDaniel P O'Brien
Mar 10, 2010·Future Microbiology·Marcus BeissnerGisela Bretzel
Mar 8, 2008·Emerging Infectious Diseases·Humberto GuerraFrançoise Portaels
Jan 22, 2008·World Journal of Gastroenterology : WJG·Jin-Gook HuhMyoung-Don Oh
Nov 4, 2011·The American Journal of Tropical Medicine and Hygiene·Benjamin MouginPierre Abgueguen
Dec 7, 2011·The American Journal of Tropical Medicine and Hygiene·Mercy M AckumeyMitchell G Weiss
Jan 1, 2013·The Pan African Medical Journal·Marius Zambou VoukingClaire Violette Tamo
Dec 18, 2013·Future Microbiology·Chih-Cheng Lai, Po-Ren Hsueh
Feb 3, 2016·BMC Complementary and Alternative Medicine·Sarojini Adusumilli, Shelley E Haydel
Oct 3, 2009·Médecine et maladies infectieuses·P AbgueguenJ Aubry
Apr 14, 2009·Clinics in Dermatology·Françoise PortaelsWayne M Meyers
Sep 17, 2008·Dermatologic Clinics·Yolanda Delgado-JimenezAmaro García-Díez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.